Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Infectious Diseases Molecular Diagnostics Kit Market Insights, Forecast to 2030

Global Infectious Diseases Molecular Diagnostics Kit Market Insights, Forecast to 2030

Industry: Medical Devices & Consumables

Published Date: 2024-04-12

Pages: 110 Pages

Report ld: 2920477

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Infectious Diseases Molecular Diagnostics Kit Market Size(US$)

CAGR 2024-2030

7.5%

Market Size,2030

USD 28,820

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 18,670 million

Market Forecast in 2030(Value)

US$ 28,820 million

CAGR

7.5%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.

Market Analysis and Insights: Global Infectious Diseases Molecular Diagnostics Kit Market

The global Infectious Diseases Molecular Diagnostics Kit market is projected to grow from US$ 18670 million in 2024 to US$ 28820 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Infectious Diseases Molecular Diagnostics Kit market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Infectious Diseases Molecular Diagnostics Kit, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Infectious Diseases Molecular Diagnostics Kit, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Infectious Diseases Molecular Diagnostics Kit revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Infectious Diseases Molecular Diagnostics Kit market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Infectious Diseases Molecular Diagnostics Kit revenue, projected growth trends, production technology, application and end-user industry.

MARKET SEGMENTATION

By Company

Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others

Segment by Application

Hospital
Third-party Testing Agency
Others

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Polymerase Chain Reaction PCR

1.2.3 Molecular Hybridization

1.2.4 Biochip

1.2.5 Others

1.3 Market by Application

1.3.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Third-party Testing Agency

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Infectious Diseases Molecular Diagnostics Kit Market Perspective (2019-2030)

2.2 Global Infectious Diseases Molecular Diagnostics Kit Growth Trends by Region

2.2.1 Infectious Diseases Molecular Diagnostics Kit Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Infectious Diseases Molecular Diagnostics Kit Historic Market Size by Region (2019-2024)

2.2.3 Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Region (2025-2030)

2.3 Infectious Diseases Molecular Diagnostics Kit Market Dynamics

2.3.1 Infectious Diseases Molecular Diagnostics Kit Industry Trends

2.3.2 Infectious Diseases Molecular Diagnostics Kit Market Drivers

2.3.3 Infectious Diseases Molecular Diagnostics Kit Market Challenges

2.3.4 Infectious Diseases Molecular Diagnostics Kit Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Infectious Diseases Molecular Diagnostics Kit by Players

3.1.1 Global Infectious Diseases Molecular Diagnostics Kit Revenue by Players (2019-2024)

3.1.2 Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Players (2019-2024)

3.2 Global Infectious Diseases Molecular Diagnostics Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Infectious Diseases Molecular Diagnostics Kit, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Infectious Diseases Molecular Diagnostics Kit Market Concentration Ratio

3.4.1 Global Infectious Diseases Molecular Diagnostics Kit Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases Molecular Diagnostics Kit Revenue in 2023

3.5 Global Key Players of Infectious Diseases Molecular Diagnostics Kit Head office and Area Served

3.6 Global Key Players of Infectious Diseases Molecular Diagnostics Kit, Product and Application

3.7 Global Key Players of Infectious Diseases Molecular Diagnostics Kit, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Diseases Molecular Diagnostics Kit Breakdown Data by Type

4.1 Global Infectious Diseases Molecular Diagnostics Kit Historic Market Size by Type (2019-2024)

4.2 Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Type (2025-2030)

5 Infectious Diseases Molecular Diagnostics Kit Breakdown Data by Application

5.1 Global Infectious Diseases Molecular Diagnostics Kit Historic Market Size by Application (2019-2024)

5.2 Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Infectious Diseases Molecular Diagnostics Kit Market Size (2019-2030)

6.2 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Type

6.2.1 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)

6.2.2 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2025-2030)

6.2.3 North America Infectious Diseases Molecular Diagnostics Kit Market Share by Type (2019-2030)

6.3 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Application

6.3.1 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)

6.3.2 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2025-2030)

6.3.3 North America Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2030)

6.4 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country

6.4.1 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2019-2024)

6.4.3 North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Infectious Diseases Molecular Diagnostics Kit Market Size (2019-2030)

7.2 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Type

7.2.1 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)

7.2.2 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2025-2030)

7.2.3 Europe Infectious Diseases Molecular Diagnostics Kit Market Share by Type (2019-2030)

7.3 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Application

7.3.1 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)

7.3.2 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2025-2030)

7.3.3 Europe Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2030)

7.4 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country

7.4.1 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2019-2024)

7.4.3 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Infectious Diseases Molecular Diagnostics Kit Market Size (2019-2030)

8.2 China Infectious Diseases Molecular Diagnostics Kit Market Size by Type

8.2.1 China Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)

8.2.2 China Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2025-2030)

8.2.3 China Infectious Diseases Molecular Diagnostics Kit Market Share by Type (2019-2030)

8.3 China Infectious Diseases Molecular Diagnostics Kit Market Size by Application

8.3.1 China Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)

8.3.2 China Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2025-2030)

8.3.3 China Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Infectious Diseases Molecular Diagnostics Kit Market Size (2019-2030)

9.2 Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Type

9.2.1 Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)

9.2.2 Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2025-2030)

9.2.3 Asia Infectious Diseases Molecular Diagnostics Kit Market Share by Type (2019-2030)

9.3 Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Application

9.3.1 Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)

9.3.2 Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2025-2030)

9.3.3 Asia Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2030)

9.4 Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Region

9.4.1 Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2019-2024)

9.4.3 Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Type

10.2.1 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Application

10.3.1 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country

10.4.1 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Infectious Diseases Molecular Diagnostics Kit Introduction

11.1.4 Roche Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.1.5 Roche Recent Developments

11.2 Qiagen

11.2.1 Qiagen Company Details

11.2.2 Qiagen Business Overview

11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Kit Introduction

11.2.4 Qiagen Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.2.5 Qiagen Recent Developments

11.3 Illumina

11.3.1 Illumina Company Details

11.3.2 Illumina Business Overview

11.3.3 Illumina Infectious Diseases Molecular Diagnostics Kit Introduction

11.3.4 Illumina Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.3.5 Illumina Recent Developments

11.4 Abbott

11.4.1 Abbott Company Details

11.4.2 Abbott Business Overview

11.4.3 Abbott Infectious Diseases Molecular Diagnostics Kit Introduction

11.4.4 Abbott Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.4.5 Abbott Recent Developments

11.5 Hologic

11.5.1 Hologic Company Details

11.5.2 Hologic Business Overview

11.5.3 Hologic Infectious Diseases Molecular Diagnostics Kit Introduction

11.5.4 Hologic Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.5.5 Hologic Recent Developments

11.6 BioMerieux

11.6.1 BioMerieux Company Details

11.6.2 BioMerieux Business Overview

11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Kit Introduction

11.6.4 BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.6.5 BioMerieux Recent Developments

11.7 Danaher (Cepheid)

11.7.1 Danaher (Cepheid) Company Details

11.7.2 Danaher (Cepheid) Business Overview

11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Introduction

11.7.4 Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.7.5 Danaher (Cepheid) Recent Developments

11.8 Myriad Genetics

11.8.1 Myriad Genetics Company Details

11.8.2 Myriad Genetics Business Overview

11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Introduction

11.8.4 Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.8.5 Myriad Genetics Recent Developments

11.9 DAAN Gene

11.9.1 DAAN Gene Company Details

11.9.2 DAAN Gene Business Overview

11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Introduction

11.9.4 DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.9.5 DAAN Gene Recent Developments

11.10 Agilent

11.10.1 Agilent Company Details

11.10.2 Agilent Business Overview

11.10.3 Agilent Infectious Diseases Molecular Diagnostics Kit Introduction

11.10.4 Agilent Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.10.5 Agilent Recent Developments

11.11 Genomic Health

11.11.1 Genomic Health Company Details

11.11.2 Genomic Health Business Overview

11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Kit Introduction

11.11.4 Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.11.5 Genomic Health Recent Developments

11.12 BD

11.12.1 BD Company Details

11.12.2 BD Business Overview

11.12.3 BD Infectious Diseases Molecular Diagnostics Kit Introduction

11.12.4 BD Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.12.5 BD Recent Developments

11.13 Foundation Medicine

11.13.1 Foundation Medicine Company Details

11.13.2 Foundation Medicine Business Overview

11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Introduction

11.13.4 Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

11.13.5 Foundation Medicine Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Polymerase Chain Reaction PCR

Table 3. Key Players of Molecular Hybridization

Table 4. Key Players of Biochip

Table 5. Key Players of Others

Table 6. Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Region (2019-2024)

Table 10. Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Region (2025-2030)

Table 12. Infectious Diseases Molecular Diagnostics Kit Market Trends

Table 13. Infectious Diseases Molecular Diagnostics Kit Market Drivers

Table 14. Infectious Diseases Molecular Diagnostics Kit Market Challenges

Table 15. Infectious Diseases Molecular Diagnostics Kit Market Restraints

Table 16. Global Infectious Diseases Molecular Diagnostics Kit Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Infectious Diseases Molecular Diagnostics Kit Revenue Share by Players (2019-2024)

Table 18. Global Top Infectious Diseases Molecular Diagnostics Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics Kit as of 2023)

Table 19. Global Infectious Diseases Molecular Diagnostics Kit Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Infectious Diseases Molecular Diagnostics Kit Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Infectious Diseases Molecular Diagnostics Kit, Headquarters and Area Served

Table 22. Global Key Players of Infectious Diseases Molecular Diagnostics Kit, Product and Application

Table 23. Global Key Players of Infectious Diseases Molecular Diagnostics Kit, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Type (2019-2024)

Table 27. Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Type (2025-2030)

Table 29. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Infectious Diseases Molecular Diagnostics Kit Revenue Share by Application (2019-2024)

Table 31. Global Infectious Diseases Molecular Diagnostics Kit Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Infectious Diseases Molecular Diagnostics Kit Revenue Share by Application (2025-2030)

Table 33. North America Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Infectious Diseases Molecular Diagnostics Kit Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Infectious Diseases Molecular Diagnostics Kit Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Infectious Diseases Molecular Diagnostics Kit Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2025-2030) & (US$ Million)

Table 65. Roche Company Details

Table 66. Roche Business Overview

Table 67. Roche Infectious Diseases Molecular Diagnostics Kit Product

Table 68. Roche Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 69. Roche Recent Developments

Table 70. Qiagen Company Details

Table 71. Qiagen Business Overview

Table 72. Qiagen Infectious Diseases Molecular Diagnostics Kit Product

Table 73. Qiagen Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 74. Qiagen Recent Developments

Table 75. Illumina Company Details

Table 76. Illumina Business Overview

Table 77. Illumina Infectious Diseases Molecular Diagnostics Kit Product

Table 78. Illumina Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 79. Illumina Recent Developments

Table 80. Abbott Company Details

Table 81. Abbott Business Overview

Table 82. Abbott Infectious Diseases Molecular Diagnostics Kit Product

Table 83. Abbott Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 84. Abbott Recent Developments

Table 85. Hologic Company Details

Table 86. Hologic Business Overview

Table 87. Hologic Infectious Diseases Molecular Diagnostics Kit Product

Table 88. Hologic Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 89. Hologic Recent Developments

Table 90. BioMerieux Company Details

Table 91. BioMerieux Business Overview

Table 92. BioMerieux Infectious Diseases Molecular Diagnostics Kit Product

Table 93. BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 94. BioMerieux Recent Developments

Table 95. Danaher (Cepheid) Company Details

Table 96. Danaher (Cepheid) Business Overview

Table 97. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product

Table 98. Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 99. Danaher (Cepheid) Recent Developments

Table 100. Myriad Genetics Company Details

Table 101. Myriad Genetics Business Overview

Table 102. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product

Table 103. Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 104. Myriad Genetics Recent Developments

Table 105. DAAN Gene Company Details

Table 106. DAAN Gene Business Overview

Table 107. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product

Table 108. DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 109. DAAN Gene Recent Developments

Table 110. Agilent Company Details

Table 111. Agilent Business Overview

Table 112. Agilent Infectious Diseases Molecular Diagnostics Kit Product

Table 113. Agilent Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 114. Agilent Recent Developments

Table 115. Genomic Health Company Details

Table 116. Genomic Health Business Overview

Table 117. Genomic Health Infectious Diseases Molecular Diagnostics Kit Product

Table 118. Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 119. Genomic Health Recent Developments

Table 120. BD Company Details

Table 121. BD Business Overview

Table 122. BD Infectious Diseases Molecular Diagnostics Kit Product

Table 123. BD Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 124. BD Recent Developments

Table 125. Foundation Medicine Company Details

Table 126. Foundation Medicine Business Overview

Table 127. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product

Table 128. Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024) & (US$ Million)

Table 129. Foundation Medicine Recent Developments

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Type: 2023 VS 2030

Figure 3. Polymerase Chain Reaction PCR Features

Figure 4. Molecular Hybridization Features

Figure 5. Biochip Features

Figure 6. Others Features

Figure 7. Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Third-party Testing Agency Case Studies

Figure 11. Others Case Studies

Figure 12. Infectious Diseases Molecular Diagnostics Kit Report Years Considered

Figure 13. Global Infectious Diseases Molecular Diagnostics Kit Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Infectious Diseases Molecular Diagnostics Kit Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Region: 2023 VS 2030

Figure 16. Global Infectious Diseases Molecular Diagnostics Kit Market Share by Players in 2023

Figure 17. Global Top Infectious Diseases Molecular Diagnostics Kit Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics Kit as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Infectious Diseases Molecular Diagnostics Kit Revenue in 2023

Figure 19. North America Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Infectious Diseases Molecular Diagnostics Kit Market Share by Type (2019-2030)

Figure 21. North America Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2030)

Figure 22. North America Infectious Diseases Molecular Diagnostics Kit Market Share by Country (2019-2030)

Figure 23. United States Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Infectious Diseases Molecular Diagnostics Kit Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Infectious Diseases Molecular Diagnostics Kit Market Share by Type (2019-2030)

Figure 27. Europe Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2030)

Figure 28. Europe Infectious Diseases Molecular Diagnostics Kit Market Share by Country (2019-2030)

Figure 29. Germany Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Infectious Diseases Molecular Diagnostics Kit Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Infectious Diseases Molecular Diagnostics Kit Market Share by Type (2019-2030)

Figure 37. China Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2030)

Figure 38. Asia Infectious Diseases Molecular Diagnostics Kit Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Infectious Diseases Molecular Diagnostics Kit Market Share by Type (2019-2030)

Figure 40. Asia Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2030)

Figure 41. Asia Infectious Diseases Molecular Diagnostics Kit Market Share by Region (2019-2030)

Figure 42. Japan Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Infectious Diseases Molecular Diagnostics Kit Market Share by Country (2019-2030)

Figure 52. Brazil Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Infectious Diseases Molecular Diagnostics Kit Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Roche Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 59. Qiagen Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 60. Illumina Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 61. Abbott Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 62. Hologic Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 63. BioMerieux Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 64. Danaher (Cepheid) Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 65. Myriad Genetics Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 66. DAAN Gene Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 67. Agilent Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 68. Genomic Health Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 69. BD Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 70. Foundation Medicine Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Kit Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Infectious Diseases Molecular Diagnostics Kit market size from 2024 to 2030? zhanKai

The annual compound growth rate of the global Infectious Diseases Molecular Diagnostics Kit market is 7.5% 2024 to 2030.

Which companies rank high in the global Infectious Diseases Molecular Diagnostics Kit market? shouQi

What was the global market size of Infectious Diseases Molecular Diagnostics Kit in 2024? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Infectious Diseases Molecular Diagnostics Kit in 2030? shouQi

Related Reports

Infectious Diseases Molecular Diagnostics Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 21280 million in 2025 and is projected to reach US$ 35060 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 115
USD 3950.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2026
The global Infectious Diseases Molecular Diagnostics Kit market was valued at US$ 21280 million in 2025 and is anticipated to reach US$ 35060 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 118
USD 2900.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Infectious Diseases Molecular Diagnostics Kit market is projected to grow from US$ 19930 million in 2024 to US$ 32840 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 142
USD 4900.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2025
The global market for Infectious Diseases Molecular Diagnostics Kit was valued at US$ 19930 million in the year 2024 and is projected to reach a revised size of US$ 32840 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-01-16
Pages: 82
USD 2900.00
(Single User License)
Infectious Diseases Molecular Diagnostics Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 19930 million in 2024 and is forecast to a readjusted size of US$ 32840 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 108
USD 3950.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2024
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published Date: 2024-01-12
Pages: 86
USD 2900.00
(Single User License)
Infectious Diseases Molecular Diagnostics Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published Date: 2024-01-08
Pages: 108
USD 3950.00
(Single User License)

Infectious Diseases Molecular Diagnostics Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 21280 million in 2025 and is projected to reach US$ 35060 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 115
USD 3950.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2026
The global Infectious Diseases Molecular Diagnostics Kit market was valued at US$ 21280 million in 2025 and is anticipated to reach US$ 35060 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-04-17
Pages: 118
USD 2900.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Infectious Diseases Molecular Diagnostics Kit market is projected to grow from US$ 19930 million in 2024 to US$ 32840 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 142
USD 4900.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2025
The global market for Infectious Diseases Molecular Diagnostics Kit was valued at US$ 19930 million in the year 2024 and is projected to reach a revised size of US$ 32840 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-01-16
Pages: 82
USD 2900.00 (Single User License)
Infectious Diseases Molecular Diagnostics Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 19930 million in 2024 and is forecast to a readjusted size of US$ 32840 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 108
USD 3950.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2024
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published: 2024-01-12
Pages: 86
USD 2900.00 (Single User License)
Infectious Diseases Molecular Diagnostics Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published: 2024-01-08
Pages: 108
USD 3950.00 (Single User License)